Oncternal Therapeutics (NASDAQ:ONCT) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research note released on Monday. The brokerage issued a hold rating on the stock. Oncternal Therapeutics Stock Performance NASDAQ ONCT opened at $0.53 on Monday. The firm has a market capitalization of $1.56 million, a P/E ratio of -0.05 and a […]
